Absorption |
Blood-Brain Barrier | BBB+ | 0.9073 |
Human Intestinal Absorption | HIA+ | 0.9886 |
Caco-2 Permeability | Caco2+ | 0.7454 |
P-glycoprotein Substrate | Non-substrate | 0.5472 |
P-glycoprotein Inhibitor | Inhibitor | 0.6382 |
Inhibitor | 0.5097 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8445 |
Distribution |
Subcellular localization | Mitochondria | 0.6582 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8128 |
CYP450 2D6 Substrate | Non-substrate | 0.8969 |
CYP450 3A4 Substrate | Non-substrate | 0.5638 |
CYP450 1A2 Inhibitor | Inhibitor | 0.9499 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.6599 |
CYP450 2D6 Inhibitor | Inhibitor | 0.5728 |
CYP450 2C19 Inhibitor | Inhibitor | 0.9452 |
CYP450 3A4 Inhibitor | Inhibitor | 0.7206 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.8133 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9682 |
Non-inhibitor | 0.9503 |
AMES Toxicity | Non AMES toxic | 0.5874 |
Carcinogens | Non-carcinogens | 0.9533 |
Fish Toxicity | High FHMT | 0.9506 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9514 |
Honey Bee Toxicity | High HBT | 0.8000 |
Biodegradation | Not ready biodegradable | 0.7479 |
Acute Oral Toxicity | II | 0.5601 |
Carcinogenicity (Three-class) | Non-required | 0.3731 |